Operating CF
$10.8B
Capex
-$576M
Free Cash Flow
$10.2B
FCF Margin
+94.7%
Cash flow waterfall for Gilead Sciences (GILD) — TTM through Q1 2026
Free cash flow: $10.2B
Cash flow breakdown for Gilead Sciences (GILD) — TTM through Q1 2026
| Line item | Amount | Running total |
|---|---|---|
| Operating Cash Flow | $10.8B | $10.8B |
| Capital Expenditure | -$576M | $10.2B |
| Free Cash Flow | $10.2B | $10.2B |
| Acquisitions | -$906M | $9.32B |
| Other Investing | -$1.13B | $8.2B |
| Share Buybacks | -$1.61B | $6.59B |
| Dividends Paid | -$4.03B | $2.55B |
| Net Debt Change | -$2.79B | -$239M |
| Other Financing & FX | -$60M | -$299M |
| Net Cash Decrease | -$298M | -$298M |
- Operating Cash Flow$10.8B
- Capital Expenditure-$576M
- Free Cash Flow$10.2B
- Acquisitions-$906M
- Other Investing-$1.13B
- Share Buybacks-$1.61B
- Dividends Paid-$4.03B
- Net Debt Change-$2.79B
- Other Financing & FX-$60M
- Net Cash Decrease-$298M
Want to see what drove the FCF change?Free Cash Flow Bridge
Frequently asked questions
Data & methodology
Gilead Sciences (GILD) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Forecast & Valuation
Operations
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement
Capital Return
- Buybacks0.93% TTM
- Dividend Profile2.47% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History5 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.